URAC, the Washington, D.C.-based nonprofit that has accredited health plans and utilization-review programs for more than three decades, confirmed in August 2026 that Guidehealth, RediMinds and SandsRx have become the first organizations in the country to earn its Health Care AI Accreditation — the credential URAC launched a year earlier, in September 2025, as what it calls the nation’s first formal accreditation program built specifically for artificial intelligence in health care.
Two Tracks, One Set of Standards
The program is split into two pathways. One is aimed at organizations that develop AI systems for clinical or administrative use — the model builders. The other targets organizations that deploy AI in care delivery, such as hospitals, health plans and medical groups that buy and operationalize third-party tools. Both tracks are judged against the same three pillars: risk management, operations and infrastructure, and performance monitoring and improvement, according to URAC’s published standards.
What Accreditors Are Actually Checking
In practice, URAC surveyors examine whether an organization can document how a model was trained and tested, whether it discloses its intended use and limitations to clinicians and patients, whether it actively monitors for degraded accuracy or emerging bias once deployed, and whether there is a defined escalation path when the AI gets something wrong. That last point has taken on new urgency as federal programs like Medicare’s AI-assisted prior-authorization pilot have drawn scrutiny for opaque denial rates, giving URAC’s accreditation a real-world example of exactly the kind of transparency gap it is trying to close.
Why Guidehealth, RediMinds and SandsRx Went First
Guidehealth, a value-based care technology company, and RediMinds, an AI software firm working across clinical documentation and diagnostics, both sought the developer-facing accreditation to reassure health-system customers that their models meet an external bar rather than asking hospitals to take vendor claims on faith. SandsRx, a pharmacy technology company, pursued accreditation on the deployment side, aiming to show payers and pharmacy benefit partners that its AI-driven workflows are actively governed rather than a black box bolted onto existing systems.
Filling a Gap Regulators Haven’t Closed
Unlike drugs or high-risk medical devices, most AI software used for documentation, scheduling, risk scoring or administrative decision support falls outside FDA’s premarket clearance requirements entirely, leaving hospitals to build their own vetting processes — often inconsistently — before adopting a new tool. URAC’s accreditation is explicitly designed to sit in that gap, giving health systems a third-party credential to point to during procurement instead of building bespoke AI-vetting committees from scratch. Several major health systems are reportedly using the accreditation as a factor in vendor selection, according to URAC’s own announcements, though the organization has not disclosed exact figures on how many contracts have referenced it.
The Skeptics: Accreditation Isn’t Regulation
Not everyone is convinced accreditation alone solves the problem. Patient advocates and some health policy researchers argue that a voluntary credential, however rigorous, lacks the enforcement teeth of an FDA clearance or a state law, and that companies can simply decline to pursue it if their AI wouldn’t pass scrutiny. Others note URAC itself is funded in part by the industry it accredits, a structural tension common to voluntary accreditation bodies in health care generally, from hospital accreditation to health-plan quality ratings. URAC counters that its standards were developed with input from clinicians, technologists and patient-safety experts, and that the program’s real test will be whether large payers and health systems begin requiring it as a condition of doing business.
What to Watch Next
With three organizations accredited as of August 2026, URAC says a larger wave of applicants is in the pipeline, and the real signal to watch is whether major health insurers or hospital systems start writing the accreditation into vendor contracts as a baseline requirement — the same way HIPAA compliance or SOC 2 certification became table stakes for health IT vendors a decade earlier. If that happens, URAC’s credential could become the de facto national standard for AI governance in health care well before Congress or federal regulators write anything resembling binding rules.
Photo: Andre / PEXELS via Pexels
